Trial intelligence / Profile preview

Azelaic Acid vs. Hydroquinone in Melasma

NCT00927771Phase 4Unknown

Sponsor
Callender Center for Clinical Research
Start
Jun 2009
Primary completion
Jun 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of azelaic acid 15% gel vehicle in melasma, sponsored by Callender Center for Clinical Research. Status: unknown.

02

Drugs

azelaic acid 15% gel vehicle
03

Conditions

melasma

Beyond the preview

Go deeper on NCT00927771.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00927771.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call